FDA 483 - Greater Baltimore Medical Center - October 26, 2023

An FDA inspection of Greater Baltimore Medical Center's Hospital Blood Bank in Towson, MD, revealed significant deficiencies in equipment calibration and validation, as well as a failure to follow written standard operating procedures for recordkeeping. These issues indicate a lack of control over critical processes for blood and blood component testing and documentation.